Skip to main content
logo
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
185.68
-1.31 (-0.70%)
Oct 26, 2026, 11:28 AM EDT - Market open

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
39,79815,3988,0834,7202,1151,855
Market Cap Growth
301.85%90.50%71.26%123.15%14.03%-29.43%
Enterprise Value
37,05013,8816,6203,9691,5251,278
Last Close Price
186.9979.6543.7428.6823.8225.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---407.5859.7863.11
PB Ratio
15.379.443.572.583.093.08
P/TBV Ratio
15.809.873.682.693.463.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---342.7843.1143.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.460.260.060.050.090.11
Net Debt / Equity Ratio
-1.05-0.98-0.95-0.97-0.85-0.85
Net Debt / EBITDA Ratio
1.701.363.153.752.282.76
Net Debt / FCF Ratio
2.231.753.794.932.473.32
Asset Turnover
---0.010.050.05
Quick Ratio
11.126.9813.9712.8910.489.66
Current Ratio
11.387.1514.2013.0610.659.77
Return on Equity (ROE)
-79.09%-58.07%-29.33%-34.75%-38.63%-34.73%
Return on Assets (ROA)
-30.12%-30.08%-18.66%-20.71%-20.83%-18.00%
Return on Capital Employed (ROCE)
-41.00%-57.30%-28.80%-24.80%-34.40%-27.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.80%-7.35%-7.42%-9.25%-11.76%-10.09%
FCF Yield
-3.07%-5.93%-7.02%-7.59%-11.12%-8.29%
Buyback Yield / Dilution
-10.45%-13.35%-48.24%-40.34%-10.74%-32.68%
SEC Filings: 10-K · 10-Q